Overall Technical outlook

Price Summary

Suven Pharmaceuticals Limited's stock started the year at 1059.0, climbed to a high of 1071.95, fell to 1054.4, and closed 0.45% up at 1063.8, with 191992 shares traded on 2025-07-16.
For the 52-week period, the stock's highest price is 1334.2, and the lowest price is 944.1.

Technicals

Support and Resistance: The current price is 1063.8, with support at 1048.2 and resistance at 1113.1. This range suggests that the price might move between these levels, with 1048.2 offering support and 1113.1 capping further gains for Suven Pharmaceuticals Limited.
SUVENPHAR supportResistance 99db22
Support/Resistance for SUVENPHAR


Aroon: The current state of the AROON is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
SUVENPHAR aroon 99db22
Aroon chart for Suven Pharmaceuticals Limited


Bol. Bands: The latest price move has seen the current price cross above the upper Bollinger Band, marking a bullish signal. This upward break indicates strong buying pressure, pushing prices beyond their normal range. Traders may see this as a sign of increasing momentum, with the potential for further upward price action.
SUVENPHAR bbands 99db22
Bolinger Bands chart for Suven Pharmaceuticals Limited


Parabolic SAR: The PSAR remains bullish, reinforcing a significant support level. This steady support suggests that the market's upward trend may continue, providing a solid foundation for potential gains for SUVENPHAR. Investors might see this as an opportunity to capitalize on the ongoing bullish sentiment.
SUVENPHAR psar 99db22
Parabolic Stop and Reverse chart for Suven Pharmaceuticals Limited


Stochastic: The stochastic indicator is currently bullish, with the K-line exceeding both the D-line and the 80 level. This configuration indicates robust upward momentum, suggesting that the market may experience further gains. Investors may interpret this as a positive signal for continued upward movement.
SUVENPHAR stoch 99db22
Stochastic chart for Suven Pharmaceuticals Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
SUVENPHAR trippleSMA 99db22
Tripple SMA chart for Suven Pharmaceuticals Limited


When evaluating a company, it is crucial to examine its fundamentals, including its financial statements, management structure, and market position. Additionally, understanding the broader industry trends, competition, and regulatory landscape helps to create a well-rounded view. By assessing both the company's internal factors and the external environment in which it operates, you can extract more valuable insights from its technical performance, such as stock price movements and trading patterns.